资产负债表(Ironwood Pharmaceuticals Inc-A)
2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
---|---|---|---|---|---|---|---|---|
截止日期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
流动资产: | ||||||||
现金及现金等价物(元) | 92,154,000.00 | 110,164,000.00 | 175,321,000.00 | 740,342,000.00 | 656,203,000.00 | 574,188,000.00 | 504,365,000.00 | 593,371,000.00 |
受限制存款及现金流动(元) | - | 788,000.00 | 788,000.00 | 1,250,000.00 | 1,250,000.00 | 1,250,000.00 | 1,250,000.00 | 1,250,000.00 |
应收账款及票据(元) | 129,122,000.00 | 124,546,000.00 | 118,990,000.00 | 115,749,000.00 | 115,458,000.00 | 116,545,000.00 | 102,357,000.00 | 106,943,000.00 |
预付款项及其他应收款流动(元) | 12,012,000.00 | 18,112,000.00 | 22,500,000.00 | 9,033,000.00 | 7,715,000.00 | 7,011,000.00 | 9,854,000.00 | 8,537,000.00 |
流动资产合计(元) | 233,288,000.00 | 253,610,000.00 | 317,599,000.00 | 866,374,000.00 | 780,626,000.00 | 698,994,000.00 | 617,826,000.00 | 710,101,000.00 |
非流动资产: | ||||||||
物业、厂房及设备(元) | 5,585,000.00 | 5,630,000.00 | 5,876,000.00 | 6,015,000.00 | 6,288,000.00 | 6,660,000.00 | 6,964,000.00 | 7,229,000.00 |
受限制存款及现金非流动(元) | - | 510,000.00 | 510,000.00 | 485,000.00 | 485,000.00 | 485,000.00 | 485,000.00 | 485,000.00 |
无形资产(元) | 3,682,000.00 | 3,889,000.00 | 4,096,000.00 | - | - | - | - | - |
预付款项及其他长期应收款非流动(元) | - | - | - | - | 14,589,000.00 | 14,439,000.00 | 14,289,000.00 | 14,143,000.00 |
递延所得税资产非流动(元) | 212,324,000.00 | 243,645,000.00 | 257,900,000.00 | 267,909,000.00 | 283,661,000.00 | 304,538,000.00 | 320,554,000.00 | 335,440,000.00 |
非流动资产其他项目(元) | 16,194,000.00 | 16,779,000.00 | 17,239,000.00 | 14,494,000.00 | 14,870,000.00 | 15,228,000.00 | 15,572,000.00 | 15,983,000.00 |
非流动资产合计(元) | 237,785,000.00 | 270,453,000.00 | 285,621,000.00 | 288,903,000.00 | 319,893,000.00 | 341,350,000.00 | 357,864,000.00 | 373,280,000.00 |
总资产(元) | 471,073,000.00 | 524,063,000.00 | 603,220,000.00 | 1,155,277,000.00 | 1,100,519,000.00 | 1,040,344,000.00 | 975,690,000.00 | 1,083,381,000.00 |
流动负债: | ||||||||
短期债务及长期负债本期部分(元) | 199,560,000.00 | 199,321,000.00 | 199,083,000.00 | - | - | - | - | - |
融资租赁负债流动(元) | 3,126,000.00 | 3,111,000.00 | 3,095,000.00 | 3,080,000.00 | 3,065,000.00 | 3,050,000.00 | 3,066,000.00 | 3,097,000.00 |
应付账款及票据(元) | 7,830,000.00 | 4,698,000.00 | 3,505,000.00 | 118,000.00 | 483,000.00 | 795,000.00 | 317,000.00 | 121,113,000.00 |
其他应付款及应计费用(元) | 65,585,000.00 | 73,449,000.00 | 99,707,000.00 | 20,645,000.00 | 21,958,000.00 | 23,271,000.00 | 19,763,000.00 | 22,294,000.00 |
流动负债其他项目(元) | - | - | - | - | 19,000.00 | 1,000.00 | 152,000.00 | 899,000.00 |
流动负债合计(元) | 276,101,000.00 | 280,579,000.00 | 305,390,000.00 | 23,843,000.00 | 25,525,000.00 | 27,117,000.00 | 23,298,000.00 | 147,403,000.00 |
非流动负债: | ||||||||
长期债务(元) | - | 198,141,000.00 | - | - | - | - | - | - |
融资租赁负债非流动(元) | 14,543,000.00 | 15,074,000.00 | 15,598,000.00 | 16,105,000.00 | 16,599,000.00 | 17,087,000.00 | 17,567,000.00 | 18,031,000.00 |
应付账款及票据非流动(元) | - | - | - | - | - | - | 395,451,000.00 | 395,053,000.00 |
衍生工具负债非流动(元) | 198,309,000.00 | - | 197,974,000.00 | 396,653,000.00 | 396,251,000.00 | 395,850,000.00 | - | - |
非流动负债其他项目(元) | 328,415,000.00 | 355,948,000.00 | 431,035,000.00 | 11,824,000.00 | 9,766,000.00 | 9,227,000.00 | 6,491,000.00 | 5,111,000.00 |
非流动负债合计(元) | 541,267,000.00 | 569,163,000.00 | 644,607,000.00 | 424,582,000.00 | 422,616,000.00 | 422,164,000.00 | 419,509,000.00 | 418,195,000.00 |
总负债(元) | 817,368,000.00 | 849,742,000.00 | 949,997,000.00 | 448,425,000.00 | 448,141,000.00 | 449,281,000.00 | 442,807,000.00 | 565,598,000.00 |
股东权益: | ||||||||
普通股(元) | 156,000.00 | 156,000.00 | 156,000.00 | 155,000.00 | 154,000.00 | 153,000.00 | 153,000.00 | 155,000.00 |
股本溢价(元) | 1,355,195,000.00 | 1,374,908,000.00 | 1,366,989,000.00 | 1,357,359,000.00 | 1,348,600,000.00 | 1,336,153,000.00 | 1,328,290,000.00 | 1,350,268,000.00 |
留存收益(元) | -1,698,615,000.00 | -1,697,528,000.00 | -1,712,849,000.00 | -650,662,000.00 | -696,376,000.00 | -745,243,000.00 | -795,560,000.00 | -832,640,000.00 |
累计其他全面收益(元) | -3,031,000.00 | -752,000.00 | - | - | - | - | - | - |
归属于母公司股东权益(元) | -346,295,000.00 | -323,216,000.00 | -345,704,000.00 | 706,852,000.00 | 652,378,000.00 | 591,063,000.00 | 532,883,000.00 | 517,783,000.00 |
少数股东权益(元) | - | -2,463,000.00 | -1,073,000.00 | - | - | - | - | - |
股东权益合计(元) | -346,295,000.00 | -325,679,000.00 | -346,777,000.00 | 706,852,000.00 | 652,378,000.00 | 591,063,000.00 | 532,883,000.00 | 517,783,000.00 |
负债及股东权益合计(元) | 471,073,000.00 | 524,063,000.00 | 603,220,000.00 | 1,155,277,000.00 | 1,100,519,000.00 | 1,040,344,000.00 | 975,690,000.00 | 1,083,381,000.00 |
公告日期 | 2024-02-16 | 2023-11-09 | 2023-08-09 | 2023-05-04 | 2023-02-16 | 2022-11-03 | 2022-08-04 | 2022-05-05 |
会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
审计意见 | ||||||||
核数师 |